2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade – A personal account
Author:
Open Access
- 1 December 2018
- journal article
- editorial
- Published by Elsevier in Genes & Diseases
- Vol. 5 (4) , 302-303
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1–Negative Human Lung CancersClinical Cancer Research, 2018
- The third group of the B7‐CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7‐H3Immunological Reviews, 2017
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationJournal of Experimental Medicine, 2000
- B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretionNature Medicine, 1999
- Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying ImmunoreceptorImmunity, 1999
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.The EMBO Journal, 1992